ACTIVE

Arega Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result6,4 M €+57,6 %over 1 year

Revenue63,4 M €+13,5 %over 1 year

Equity9,8 M €-12,2 %over 1 year

Workforce53,3 ETP+1,1 %over 1 year

Identity

Source · BCE/KBO

Arega Pharma is a Public limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mechelen. It employs on average 53,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0722.544.585
Incorporation: 08/03/2019
Legal form: Public limited company
Registered office: Stationsstraat 55
2800 Mechelen · FlandreSee on map
Contributed capital: 220 000,00 €
Latest accounts: 31/12/2025
Average workforce: 53,3 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 46389Wholesale of other food, including fish, crustaceans and molluscs 46389Wholesale of other food, including fish, crustaceans and molluscs 46442Wholesale of china and glassware and cleaning materials 46442Wholesale of china and glassware and cleaning materials+4

Joint committees (2)

200
2000

Contacts

1 public detail availableLog in to view

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 6 filings

Trend over 6 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	63,4 M €	+13.5%	55,8 M €	+9.2%	51,2 M €	+4.2%	49,1 M €	+10.0%	44,6 M €
EBITDA	9 M €	+77.0%	5,1 M €	+42.0%	3,6 M €	-5.5%	3,8 M €	+33.8%	2,8 M €
Operating result	8 M €	+40.0%	5,7 M €	+61.8%	3,5 M €	+42.6%	2,5 M €	-12.8%	2,8 M €
Net result	6,4 M €	+57.6%	4 M €	+65.1%	2,4 M €	+41.3%	1,7 M €	-8.1%	1,9 M €
Balance sheet
Equity	9,8 M €	-12.2%	11,2 M €	+56.5%	7,1 M €	+52.0%	4,7 M €	+58.3%	3 M €
Total assets	54,2 M €	+25.8%	43 M €	+46.5%	29,4 M €	+42.7%	20,6 M €	+20.3%	17,1 M €
Cash	5,6 k €		–		–		–		1,7 M €
Debts	43,4 M €	+38.8%	31,3 M €	+45.2%	21,5 M €	+41.5%	15,2 M €	+8.3%	14,1 M €
Other
Workforce	53,3 ETP	+1.1%	52,7 ETP	-3.8%	54,8 ETP	+4.0%	52,7 ETP	+4.4%	50,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 10 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
BrandNomad1030.693.492Represented by Ann Tielemans	Director01/04/2026 → 30/06/2032
CmmB0759.858.606Represented by Anne-Sophie Gernay	Director01/04/2026 → 30/06/2032
EXACTLY RIGHT MANAGEMENT1028.093.793Represented by Stefanie Pieraets	Managing director01/04/2026 → 30/06/2032
JALISSENSE1030.938.467Represented by Stefan De Ridder	Director01/04/2026 → 30/06/2032
Metriora1033.922.901Represented by Alain De Buf	Director01/04/2026 → 30/06/2032
Organova1028.463.086Represented by Dirk Schollaert	Director01/04/2026 → 30/06/2032
R.Chibel1030.555.714Represented by Rémy Chibel	Director01/04/2026 → 30/06/2032

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
AIR-WORX0669.513.794Represented by Christiaan Olyslager	Mandate2022 accounts
Alain De Buf	Mandate2024 accounts
Ann Tielemans	Mandate2024 accounts
Anne-Sophie Gernay	Mandate2024 accounts

Other companies at this address

Stationsstraat 55 2800 Mechelen

Company	CBE no.
ALCON● Active	0429.184.121
Arega Health● Active	0721.744.435
Hydra● Active	0801.606.515
Juno Topco● Active	0783.484.935
Let's App● Active	0752.709.706
Protostars● Active	0649.435.388
Spectricity● Active	0685.594.317
Vyntra Belgium● Active	0838.618.151
Vyntra Holding● Active	0783.560.852

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	08/03/2019
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	22 months
Filing date	13/07/2026	30/07/2025	13/08/2024	17/10/2023	06/10/2022	07/07/2021
General meeting	30/06/2026	30/06/2025	01/07/2024	15/07/2023	15/07/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	13/07/2026	Dutch	PDF
Full model	31/12/2024	30/06/2025	30/07/2025	Dutch	PDF
Full model	31/12/2023	01/07/2024	13/08/2024	Dutch	PDF
Full model	31/12/2022	15/07/2023	17/10/2023	Dutch	PDF
Full model	31/12/2021	15/07/2022	06/10/2022	Dutch	PDF
Full model	31/12/2020	30/06/2021	07/07/2021	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 10 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
BrandNomad1030.693.492Represented by Ann Tielemans	Director01/04/2026 → 30/06/2032
CmmB0759.858.606Represented by Anne-Sophie Gernay	Director01/04/2026 → 30/06/2032
EXACTLY RIGHT MANAGEMENT1028.093.793Represented by Stefanie Pieraets	Managing director01/04/2026 → 30/06/2032
JALISSENSE1030.938.467Represented by Stefan De Ridder	Director01/04/2026 → 30/06/2032
Metriora1033.922.901Represented by Alain De Buf	Director01/04/2026 → 30/06/2032
Organova1028.463.086Represented by Dirk Schollaert	Director01/04/2026 → 30/06/2032
R.Chibel1030.555.714Represented by Rémy Chibel	Director01/04/2026 → 30/06/2032

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
AIR-WORX0669.513.794Represented by Christiaan Olyslager	Mandate2022 accounts
Alain De Buf	Mandate2024 accounts
Ann Tielemans	Mandate2024 accounts
Anne-Sophie Gernay	Mandate2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other26/08/2026
DIVERSEN
PDF
Mandates12/08/2026
ONTSLAGEN, BENOEMINGEN
PDF
Mandates16/04/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/04/2026
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring08/08/2025
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring28/05/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Registered office10/03/2025
ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
PDF
Mandates21/02/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings6 filings

Mandates

CmmB

EXACTLY RIGHT MANAGEMENT

Organova

R.Chibel

BrandNomad

JALISSENSE

Metriora

AIR-WORX

EXSCENSUS BEHEER BV

THOMSON MANAGEMENT BV

Dirk Schollaert

Anne-Sophie Gernay

Show the 5 other mandates

20192020202120222023202420252026202720282029203020312032

Arega Pharma

Stationsstraat 55, 2800 MechelenLaarstraat 16, 2610 Wilrijk (Antwerp)

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Stationsstraat 55, 2800 MechelenCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00286063
Laarstraat 16, 2610 Wilrijk (Antwerp)	accounts 2021 → 2023	Accounts 2023 · 2024-00341631

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Arega PharmaCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00286063

Events

2025
Annual accounts 20256,4 M €↑
2024
Annual accounts 20244 M €↑
2023
Annual accounts 20232,4 M €↑
2022
Annual accounts 20221,7 M €↓
2021
Annual accounts 20211,9 M €↑
2020
Annual accounts 2020885,4 k €
08/03/2019
IncorporationPublic limited company

Arega Pharma

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events